Growth Metrics

Nuwellis (NUWE) EBITDA Margin (2013 - 2026)

Nuwellis posted quarterly EBITDA Margin of 188.97% for Q1 2026, down 3057.0% year-on-year from 6.39% in Q1 2025, and down 94.1% on a QoQ basis from 97.36% in Q4 2025.

Nuwellis (NUWE) has 14 years of EBITDA Margin data on file, last reported at 188.97% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 3057.0% year-over-year to 188.97%; the trailing twelve-month figure through Mar 2026 stood at 216.58% (down 10439.0% YoY), and the FY2025 full-year result was 211.2%, down 8327.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 188.97%, down from 97.36% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 99.45% in Q3 2024 and bottomed at 728.0% in Q2 2025.
  • The 5-year median for EBITDA Margin is 188.97% (2026), against an average of 196.43%.
  • The widest annual swing landed in 2024, when EBITDA Margin jumped 23917 bps; it then slumped 37581 bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 77.98% in 2022, then slumped by 180 bps to 218.42% in 2023, then jumped by 71 bps to 63.26% in 2024, then sank by 54 bps to 97.36% in 2025, then sank by 94 bps to 188.97% in 2026.
  • The last three EBITDA Margin figures came in at 188.97% (Q1 2026), 97.36% (Q4 2025), and 21.06% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn -188.97%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -188.97%
Dec 31, 2025 -97.36%
Sep 30, 2025 21.06%
Jun 30, 2025 -728.00%
Mar 31, 2025 -158.40%
Dec 31, 2024 -63.26%
Sep 30, 2024 99.45%
Jun 30, 2024 -352.19%
Mar 31, 2024 -233.66%
Dec 31, 2023 -218.42%
Sep 30, 2023 -139.72%
Jun 30, 2023 -233.45%
Mar 31, 2023 -355.20%
Dec 31, 2022 -77.98%
Sep 30, 2022 -187.31%
Jun 30, 2022 -193.63%
Mar 31, 2022 -232.35%
Dec 31, 2021 -265.23%
Sep 30, 2021 -284.51%
Jun 30, 2021 -188.64%
Mar 31, 2021 -272.37%
Dec 31, 2020 -210.13%
Sep 30, 2020 -224.11%
Jun 30, 2020 -210.63%
Mar 31, 2020 -280.43%
Dec 31, 2019 -325.75%
Sep 30, 2019 -360.06%
Jun 30, 2019 -264.34%
Mar 31, 2019 -389.22%
Dec 31, 2018 -284.06%
Sep 30, 2018 -311.23%
Jun 30, 2018 -380.62%
Mar 31, 2018 -419.77%
Dec 31, 2017 -858.97%
Sep 30, 2017 -297.60%
Jun 30, 2017 -285.07%
Mar 31, 2017 -104.44%
Dec 31, 2016 -388.74%
Sep 30, 2016 -722.47%
Mar 31, 2015 -11,954.24%
Dec 31, 2014 -3,770.06%
Sep 30, 2014 -10,364.41%
Mar 31, 2014 -10,764.41%
Sep 30, 2013 -10,508.47%